3 completed, 2 unknown. 5 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 5 | Completed 3, Unknown 2 |
Follow plerixafor: new trials by email Literature Review of plerixafor trials Research Report on plerixafor
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Plerixafor for Poorly Mobilized Lymphoma Plerixafor,G-CSF - Lymphoma | Phase 4 | Unknown | Peking University | 140 | 2022-12-19 | 2023-03-13 |
| Mobilization of Stem Cells With AMD3100 (Plerixafor) in Combination With G-CSF in Multiple Myeloma Patients plerixafor + G-CSF - Autologous Haematopoietic Stem Cell Transplant | Phase 4 | Completed | Sanofi | 53 | 2021-10-22 | 2025-09-22 |
| Stem Cell Mobilization With Plerixafor in Diabetic vs Control Subjects Mozobil - Diabetes | Phase 4 | Completed | University of Padova | 20 | 2014-02-01 | 2014-10-24 |
| Stem Cell Harvesting Using GCSF Plus Plerxiafor, in First -Line, for Heavily Pre- Treated Pediatric Oncology Patients. Plerixafor - Autologous Stem Cell Transplantation | Phase 4 | Unknown | Tel-Aviv Sourasky Medical Center | 30 | 2014-02-01 | 2013-12-10 |
| Evaluation of Approved Weight-Based Dose Compared to Fixed Dose of Plerixafor in Patients With Non-Hodgkin's Lymphoma (NHL) Weighing Less Than 70 Kilograms Granulocyte-colony stimulating factor (G-CSF), Fixed Dose Plerixafor, Weight-Based Plerixafor - Non-Hodgkin's Lymphoma | Phase 4 | Completed | Genzyme, a Sanofi Company | 61 | 2010-10-01 | 2014-02-25 |
Diabetes Mellitus (1) · Lymphoma (1) · Lymphoma, Non-Hodgkin (1)
Genzyme, a Sanofi Company (1) · Peking University (1) · Sanofi (1) · Tel-Aviv Sourasky Medical Center (1) · University of Padova (1)
China (2) · Canada (1) · Italy (1) · South Korea (1) · Taiwan (1) · United States (1)